Eli Lilly and Company (LLY)

Eli Lilly Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	2,819	2,067	3,819	3,657	2,338
Short-Term Investments	109.1	144.8	90.1	24.2	101
Cash & Cash Equivalents	2,928	2,212	3,909	3,681	2,439
Cash Growth	32.37%	-43.41%	6.17%	50.97%	-67.09%
Receivables	11,336	8,559	8,127	6,929	5,542
Inventory	5,773	4,310	3,886	3,980	3,191
Other Current Assets	5,690	2,954	2,531	2,872	2,539
Total Current Assets	25,727	18,035	18,452	17,462	13,710
Property, Plant & Equipment	12,914	10,144	8,985	8,682	7,873
Long-Term Investments	3,052	2,902	3,213	2,967	1,962
Goodwill and Intangibles	11,846	11,280	11,584	11,217	10,297
Other Long-Term Assets	10,467	7,130	6,572	6,306	5,444
Total Long-Term Assets	38,279	31,455	30,354	29,171	25,577
Total Assets	64,006	49,490	48,806	46,633	39,286
Accounts Payable	2,599	1,931	1,671	1,607	1,405
Current Debt	6,905	1,501	1,538	8.7	1,499
Other Current Liabilities	17,790	13,707	11,844	10,866	8,871
Total Current Liabilities	27,293	17,138	15,053	12,482	11,775
Long-Term Debt	18,321	14,738	15,346	16,587	13,818
Other Long-Term Liabilities	7,529	6,839	9,252	11,740	10,994
Total Long-Term Liabilities	25,849	21,576	24,599	28,326	24,812
Total Liabilities	53,143	38,714	39,651	40,808	36,587
Total Debt	25,225	16,239	16,885	16,595	15,317
Debt Growth	55.34%	-3.83%	1.74%	8.34%	48.73%
Retained Earnings	10,312	10,043	8,959	7,830	4,920
Comprehensive Income	-4,327	-3,844.6	-4,343.1	-6,496.4	-6,523.6
Shareholders' Equity	10,772	10,650	8,979	5,642	2,607
Net Cash / Debt	-22,297.6	-14,026.8	-12,976.1	-12,914	-12,878.7
Net Cash Per Share	-24.69	-15.51	-14.23	-14.15	-13.76
Working Capital	-1,566.2	896.3	3,400	4,981	1,934
Book Value Per Share	11.97	11.81	9.90	6.22	2.80

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).